ResMed | RMD - Capital Social Ordinario

Precio De Mercado
228.80
Cambio Diario
-1.89 -0.82%
Mensual
-0.78%
Anual
8.18%
Q2 Expectativa
222.62




Capital Social Ordinario Cambio Fecha
Ansell USD 142.94M 885.26M 2025-12
Artivion USD 47.84M 468K 2025-12
AtriCure USD 49.7M 10K 2025-09
Baxter International USD 514.28M 168.72M 2025-12
Cochlear AUD 65.4M 1.12B 2025-12
Cooper Companies USD 195.1M 3.71M 2025-12
CSL USD 482.13M 93.87M 2025-12
Dexcom USD 384.8M 5.2M 2025-12
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Fisher Paykel Healthcare NZD 587.25M 1.35M 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Idexx Laboratories USD 79.85M 154K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Philips EUR 951.29M 310K 2025-12
Ramsay Health Care AUD 229.93M 29.81K 2025-12
ResMed USD 145.97M 25K 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Steris USD 98.15M 344K 2025-12
Teleflex USD 44.19M 1000 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12